Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass - Full Text View

Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (Stroke08)

This study is currently recruiting participants.

Verified by Klinikum Ludwigshafen, December 2008

Sponsored by:	Klinikum Ludwigshafen
Information provided by:	Klinikum Ludwigshafen
ClinicalTrials.gov Identifier:	NCT00812656

Purpose

The purpose of this study is to investigate changes in new plasma stroke biomarker panel in patients undergoing cardiac surgery with the use of cardiopulmonary bypass.

Condition
Cardiac Surgery

MedlinePlus related topics: Heart Surgery

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

Further study details as provided by Klinikum Ludwigshafen:

Primary Outcome Measures:

Change in stroke index [ Time Frame: day before surgery; first and second day postoperatively ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	50
Study Start Date:	December 2008
Estimated Study Completion Date:	April 2009
Estimated Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts
Stroke Panel group Patients undergoing cardiac surgery with the use of cardiopulmonary bypass

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Adult patients undergoing cardiac surgery with the use of cardiopulmonary bypass

Criteria

Inclusion Criteria:

Age > 18 years
Elective cardiac surgery with the use of cardiopulmonary bypass

Exclusion Criteria:

Patients undergoing emergent procedures
Patients with preoperative mechanical support

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00812656

Contacts

Contact: Stefan W Suttner, MD	0621503 ext 3000	suttner@gmx.de
Contact: Joachim Boldt, MD	0621503 ext 3000	boldtj@gmx.net

Locations

Germany, RLP
Klinikum Ludwigshafen	Recruiting
Ludwigshafen, RLP, Germany, 67063
Contact: Stefan W Suttner, MD 0621503 ext 3000 suttner@gmx.de
Contact: Joachim Boldt, MD 0621503 ext 3000 boldtj@gmx.net
Principal Investigator: Stefan W Suttner, MD

Sponsors and Collaborators

Klinikum Ludwigshafen

Investigators

Principal Investigator:

Stefan W Suttner, MD

Klinikum Ludwigshafen

More Information

Responsible Party:	Klinikum Ludwigshafen ( Prof. Dr. J. Boldt )
Study ID Numbers:	StrokePanel08
Study First Received:	December 19, 2008
Last Updated:	December 19, 2008
ClinicalTrials.gov Identifier:	NCT00812656
Health Authority:	Germany: Federal Institute for Drugs and Medical Devices

Study placed in the following topic categories:

Cerebral Infarction
Stroke

ClinicalTrials.gov processed this record on January 13, 2009